In a world where innovation in health & healthcare is essential, complex ecosystems are subjected to unprecedented pressures. Conserving the genetic heritage of life on earth is a top priority. Apart from being a profound ethical issue, applications ranging from future medical inventions to enhancing food supply stand to benefit greatly from biodiversity banking. Every species that is lost diminishes society’s potential to respond to future threats. I-arks’ objectives encompass to address this in a healthy and innovative way.
Peter Doherty, DVM, PhD, Nobelprize winner in physiology or medicine
Innovation is the key driver to discover new and innovative treatments and preventive measures in the healthcare sector. In order to ensure a constant innovation in R&D and human longevity within the healthcare environment, biodiversity and genetic heritage is of utmost importance – now and in the future. Therefore, the work of I-ARKS as the first worldwide start-up and innovation platform is very relevant to make an exportable and high quality back-up of animal life on earth
Prof. Dr. Mads Krogsgaard Thomsen, DVM, PhD, CEO Novo Nordisk Foundation & former Chief Science Officer R&D Management, Novo Nordisk A/S &Chairman Board of Directors, University of Copenhaegen